Literature DB >> 208851

The effect of cyproterone acetate on adrenal cortical function in children with precocious puberty.

F Heinze, W M Teller, H L Fehm, A Joos.   

Abstract

8 children with precocious puberty were treated with cyproterone acetate (CPA). During treatment there were no definite clinical signs of depressed adrenocortical function. The plasma cortisol concentrations were grossly depressed and the diurnal cortisol rhythm was abolished. Two months after discontinuation of CPA treatment the adrenocortical function had greatly improved. The lysin-vasopressin stimulation test revealed in one child a normal, in another child an exaggerated ACTH response during CPA therapy. Fasting plasma ACTH concentrations were elevated compared with normal controls, but they were very low compared with patients with Addison's disease. The results suggest that CPA has a twofold effect leading to adrenocortical insufficiency: i.e., inhibition of cortisol secretion by the adrenals themselves and inhibition of ACTH secretion at the hypothalamopitiuitary level.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208851     DOI: 10.1007/bf00496993

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Treatment of precocious puberty with cyproterone acetate.

Authors:  E A Werder; G Mürset; M Zachmann; C G Brook; A Prader
Journal:  Pediatr Res       Date:  1974-04       Impact factor: 3.756

2.  Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man.

Authors:  K H Voigt; H L Fehm; R Reck; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1974-06-01

3.  Improvement of adult height prognosis in precocious puberty by cyproterone acetate.

Authors:  E Bossi; R P Zurbrügg; E E Joss
Journal:  Acta Paediatr Scand       Date:  1973-07

4.  Antiandrogens and reproductive development.

Authors:  F Neumann; W Elger; H Steinbeck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1970-08-06       Impact factor: 6.237

5.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

Review 6.  Pharmacology and potential use of cyproterone acetate.

Authors:  F Neumann
Journal:  Horm Metab Res       Date:  1977-01       Impact factor: 2.936

7.  Cyproterone acetate and adrenocortical function.

Authors:  K E von Mühlendahl; S Korth-Schütz; R Müller-Hess; H Helge; B Weber
Journal:  Lancet       Date:  1977-05-28       Impact factor: 79.321

8.  Cyproterone acetate.

Authors:  W J Jeffcoate; C R Edwards; L H Rees; G M Besser
Journal:  Lancet       Date:  1976-11-20       Impact factor: 79.321

9.  Urinary androgen response of 8 girls with precocious puberty given cyproterone acetate.

Authors:  D Gupta; K Rager; R Huenges; J R Bierich
Journal:  Endokrinologie       Date:  1975-07

10.  Corticosteroid-like effect of cyproterone and cyproterone acetate in mice.

Authors:  P D Broulik; L Starka
Journal:  Experientia       Date:  1975-11-15
View more
  2 in total

1.  The long-term effect of cyproterone acetate on growth in girls with idiopathic precocious puberty. Androcur Study Group in Japan.

Authors:  K Kato; M Fujimoto; I Hibi; S Suwa; N Shimizu
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

2.  Cyproterone acetate treatment in precocious puberty.

Authors:  R Lorini; A Colombo; A G Ugazio; A Salvatoni; M Cisternino; D Larizza; E Polito; V Monafo; M Bozzola; F Severi
Journal:  J Endocrinol Invest       Date:  1981 Jul-Sep       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.